Impact of Epoetin Beta on Dialyzer Clearance and Heparin Requirements
- 1 December 1991
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 18 (6) , 668-673
- https://doi.org/10.1016/s0272-6386(12)80607-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Effect of Erythropoietin Administration on Blood and Plasma Viscosity in Hemodialysis PatientsAnnual Northeast Bioengineering Conference, 1989
- Are High Flux Dialysis and Erythropoietin Treatment in a Collision Course?Annual Northeast Bioengineering Conference, 1989
- Recent Developments in the Anemia of Chronic Renal FailureSeminars in Dialysis, 1989
- What Will Be the Impact of Erythropoietin on Chronic Dialysis?Seminars in Dialysis, 1989
- Dose-Finding, Double-Blind, Clinical Trial of Recombinant Human Erythropoietin (Chugai) in Japanese Patients with End-Stage Renal DiseasePublished by S. Karger AG ,1988
- IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETINThe Lancet, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987